Cite

HARVARD Citation

    Murphy, A. et al. (2020). A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer. Clinical and translational science. 13 (6), pp. 1178-1188. [Online]. 
  
Back to record